Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Antibodies
Antibodies
Bococizumab
Bococizumab from MedChemExpress
Be the first to write a review!
Citations:
(2)
Supplier Page
Supplier Page from
MedChemExpress for
Bococizumab
Bulk Request
Description
Bococizumab (PF-04950615) is an anti-human PCSK9 inhibitory antibody that reduces LDL cholesterol levels. Bococizumab can be used in the research of hypercholesterolemia
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
Bococizumab
Company
MedChemExpress
Price
$420.00
Supplier Page
View Company Product Page
Catalog Number
HY-P99187
Quantity
1 mg
Applications
Bioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Type
Chemical
Purity
99.80%
Research Area
Metabolic Disease; Cardiovascular Disease
Molecule Name
Bococizumab
Add to Compare List
MedChemExpress
1 Deer Park Drive, Suite F
MONMOUTH JUNCTION
,
NJ
08852
United States
Phone
: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910
Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com
Company Profile
Website:
medchemexpress.com
Citations (2)
(1)
Efficacy and Safety of Bococizumab (RN316/PF-04950615), a Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9, in Hypercholesterolemic Japanese Subjects Receiving a Stable Dose of Atorvastatin or Treatment-Naive - Results From a Randomized, Placebo-Controlled, Dose-Ranging Study
Circulation journal : official journal of the Japanese Circulation Society
September 25, 2017
Yokote K, Kanada S, Matsuoka O, Sekino H, Imai K, Tabira J, Matsuoka N, Chaudhuri S, Teramoto T.
(2)
Decreased maternal and fetal cholesterol following maternal bococizumab (anti-PCSK9 monoclonal antibody) administration does not affect rat embryo-fetal development
Regulatory toxicology and pharmacology : RTP
November 1, 2015
Campion SN, Han B, Cappon GD, Lewis EM, Kraynov E, Liang H, Bowman CJ.
<<
<
>
>>
Reviews
Be the First to Write a Review!
Bococizumab from MedChemExpress
Supplier Page
View Company Product Page
$420.00
Product Specs
Company Info
Citations
Reviews
Back To Top